{"product_id":"danlol-2-5mg-tablet-1-box-1-strip-1-strip-14-tablets","title":"Danlol 2.5Mg Tablet (1 Box = 1 Strip) (1 Strip = 14 Tablets)","description":"\u003cdiv class=\"productDescription_descriptionSectionGroup__cgws9 MuiBox-root css-0\"\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper__qrHVG\"\u003e\n\u003cdiv id=\"SPECIFICATION\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eDanlol 2.5Mg Tablet 1 Box = 1 Strip.\u003c\/b\u003e\u003c\/p\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eSpecification\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eRequires Prescription (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eYes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eGenerics\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eNebivolol HCl\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eUsed For\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eHypertension\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eHow it works\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eNebivolol is a ß1 selective adrenoceptor antagonist whose hemodynamic effects differ from those of classical ß-adrenoceptor antagonist as a result of a vasodilating action. It has mild vasodilating properties attributed to its interaction with the L-arginine\/nitric oxide path way, a property not shared by other ß-blockers. Nebivolol lacks intrinsic sympathomimetic and membrane stabilizing activity at therapeutically relevant concentrations. At clinically relevant doses, nebivolol does not demonstrate a1-adrenergic receptor blockade activity.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"USAGE AND SAFETY\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eUsage And Safety\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDosage\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eNebivolol HCl\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eSide Effects\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eCommon: Headache, dizziness, paresthesia, dyspnea, constipation, nausea, diarrhea, tiredness, edema.Uncommon: Nightmares, depression, impaired vision, bradycardia, heart failure, slowed AV conduction\/AV-block, hypotension, (increase of) intermittent claudication, bronchospasm, dyspepsia, flatulence, vomiting, pruritus, rash, erythematous, impotence.Rare: Syncope, psoriasis aggravated.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDrug Interactions\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003ePhenylalkylamine [verapamil] and benzothiazepine [diltiazem] classes) or antiarrhythmic agents such as disopyramide , digitalis glycosides and ß-blockers , reserpine or guanethidine , clonidine , CYP2D6 inhibitors (quinidine, propafenone, fluoxetine, paroxetine ) , Cimetidine , Sildenafil.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eIndication\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eFor the treatment of essential hypertension, stable, mild and moderate chronic heart failure in addition to standard therapies in elderly patients 70 years and may be used alone or in combination with other anti-hypertensive agents.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWhen not to Use\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eNebivolol is contraindicated in patients with:- Hypersensitivity to the active substance or to any of the components.- Severe hepatic insufficiency.- Acute heart failure, cardiogenic shock or episodes of heart failure decompensation requiring I.V. inotropic therapy.- Sick sinus syndrome, including sino-atrial block.- Second and third degree heart block (without a pacemaker).- History of bronchospasm and bronchial asthma.- Untreated phaeochromocytoma.- Metabolic acidosis.- Bradycardia (heart rate \u0026lt; 60bpm prior to start of therapy).- Hypotension (systoli c blood pressure \u0026lt; 90mmHg).- Severe peripheral circulatory disturbances.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"PRECAUTIONS\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003ePrecautions\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePrecaution\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eIn patients who have compensated congestive heart failure, nebivolol should be administered cautiously. If heart failure worsens, discontinuation of nebivolol should be considered.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"WARNINGS\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eWarnings\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 1\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eCare should be taken in diabetic patients however, as nebivolol may mask certain symptoms of hypoglycemia (tachycardia, palpitations). ß-adrenergic blocking agents may mask tachycardic symptoms in hyperthyroidism. Abrupt withdrawal may intensify symptoms.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 2\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eThe treatment with nebivolol is not recommended to be stopped abruptly since this might lead to a transitory worsening of heart failure. If discontinuation is necessary, the dose should be gradually decreaseddivided into halves weekly. If the angina worsens or acute coronary insufficiency develops, it is recommended that nebivolol be promptly reinstituted, at least temporarily.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 3\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eß-blockers can precipitate or aggravate symptoms of arterial insufficiency in patients with peripheral vascular diseases. Caution should be exercised in these patients.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"ADDITIONAL INFORMATION\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eAdditional Information\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePregnancy category\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eAlways consult your physician before using any medicine.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eStorage (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eStore this medicine at room temperature, away from direct light and heat.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"GENIX PHARMA PRIVATE LIMITED","offers":[{"title":"Default Title","offer_id":45718217982138,"sku":null,"price":207.0,"currency_code":"PKR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0658\/7511\/6218\/files\/WhatsAppImage2026-03-18at3.18.48PM_1.jpg?v=1773893067","url":"https:\/\/multanpluspharmacy.com\/products\/danlol-2-5mg-tablet-1-box-1-strip-1-strip-14-tablets","provider":"Multan Plus Pharmacy","version":"1.0","type":"link"}